ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ADAP Advocacy Publishes Infographics on 340B Drug Pricing Program





Infographics Highlight Excessive Hospital CEO Compensation

WASHINGTON, DC, November 25, 2025 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, published infographics highlighting excessive executive compensation packages among hospital CEOs and the impact on patients. The infographics complement the recently released commercial and are part of the ongoing 340B national advocacy campaign, "Is the 340B Drug Pricing Program the Next 'Too Big to Fail'?"

The '340B Too Big to Fail – Executive Compensation – Part 1' infographic focuses on the CEO pay gap relative to frontline nurses and on how the 340B Drug Pricing Program was designed to help poor patients access healthcare services. Yet, despite this program growing to $66 billion, manufacturer rebates are being used to fund excessive compensation for hospital CEOs.

The '340B Too Big to Fail – Executive Compensation – Part 2' infographic showcases how CEO pay has grown exponentially after hospital covered entities became eligible to participate in the program. The 340B Program wasn't designed to pad the pockets of these healthcare executives.

The two-part infographic series can be downloaded online here: https://www.adapadvocacy.org/publications.html#i.

To learn more about ADAP Advocacy, the 340B Drug Pricing Program, or the new '340B Too Big to Fail' infographics, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.78
+0.00 (0.00%)
AAPL  278.78
+0.00 (0.00%)
AMD  221.42
+0.00 (0.00%)
BAC  54.08
+0.00 (0.00%)
GOOG  320.83
+0.00 (0.00%)
META  650.13
+0.00 (0.00%)
MSFT  478.56
+0.00 (0.00%)
NVDA  183.78
+0.00 (0.00%)
ORCL  223.01
+0.00 (0.00%)
TSLA  451.45
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.